3 Results for "

(2S,3R,4S)-ASX-173

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "(2S,3R,4S)-ASX-173" in MCE Product Catalog:

Cat. No.: HY-175282A
CAS No.: 2748800-07-7
Research Areas:  

Cancer

(2S,3R,4S)-ASX-173 is the (2S,3R,4S)-enantiomer of ASX-173 (HY-175282). ASX-173 is an orally active inhibitor of asparagine synthetase (ASNS) (IC50 = 0.113 μM, Ki = 0.4 nM). ASX-173 enhances the anticancer activity of L-asparaginase (ASNase) (HY-P1923). ASX-173 disrupts nucleotide synthesis and induces leukemia cell cycle arrest, apoptosis and autophagy in leukemia cells in combination with ASNase. ASX-173 slows the growth of OCI-AML2 xenografts in combination with ASNase. ASX-173 is indicated for the study of acute lymphoblastic leukemia, acute myeloid leukemia, colorectal cancer, and other cancers .
loading...
    loading...
Cat. No.: HY-158104
Target:  

ATF6

Research Areas:  

Others

LPPM-8 is a ligand of Med25 and an inhibitor of Med25 protein-protein interactions (PPIs). LPPM-8 engages Med25 through interaction with the H2 face of its Activator Interaction Domain and stabilizes full-length protein in the cellular proteome. LPPM-8 is an orthosteric inhibitor of H2-binding transcriptional activators (such as ATF6a). LPPM-8 can be used for studying Med25 and Mediator complex biology .
loading...
    loading...
Cat. No.: HY-P2047
CAS No.: 82987-09-5
Synonyms: Antibiotic FR-900201
Target:  

Antibiotic Bacterial

Research Areas:  

Infection

Lavendomycin is a peptide antibiotic from Streptomyces. Lavendomycin inhibits Gram-positive bacteria .
loading...
    loading...